Your Ad Here

Medical Links

Your Ad Here


Teenage Headaches Not Related To Gadgets

February 9th, 2010 by admin

Use of most electronic media is not associated with headaches, at least not in adolescents. A study of 1025 13-17 year olds, published in the open access journal BMC Neurology, found no association between the use of computer games, mobile phones or television and the occurrence of headaches or migraines

More: continued here

Posted in Uncategorized | No Comments »

Ozone Detection

January 20th, 2010 by admin

Researchers in Freiburg have developed a highly-sensitive, miniaturized mobile ozone sensor which can be used not only in air, but also in water and in the vicinity of explosive gases. The Fraunhofer Institute for Applied Solid State Physics IAF in Freiburg is developing improved chemical sensors that are not prohibitively expensive…

More: continued here

Posted in Uncategorized | No Comments »

SUMAVEL(TM) DosePro(TM) Available In The United States To Treat Acute Migraine And Cluster Headaches

January 15th, 2010 by admin

Zogenix, Inc. (”Zogenix”), a privately held pharmaceutical company, and Astellas Pharma U.S., Inc. (”Astellas”) announced the U.S. commercial launch of SUMAVEL™ DosePro™ (sumatriptan injection) needle-free delivery system. In July 2009, the U.S…

More: continued here

Posted in Uncategorized | No Comments »

Migraine And Depression May Share Genetic Component

January 14th, 2010 by admin

New research shows that migraine and depression may share a strong genetic component. The research is published in the January 13, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology…

More: continued here

Posted in Uncategorized | No Comments »

Why Light Worsens Migraine Headaches

January 12th, 2010 by admin

Ask anyone who suffers from migraine headaches what they do when they’re having an attack, and you’re likely to hear “go into a dark room.” And although it’s long been known that light makes migraines worse, the reason why has been unclear…

More: continued here

Posted in Uncategorized | No Comments »

MAP Pharmaceuticals Announces FDA Will Not Require A Second Pivotal Efficacy Study For LEVADEX(TM) NDA Submission

January 12th, 2010 by admin

MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) announced that the U.S. Food and Drug Administration (FDA) has informed the Company that a second pivotal efficacy study is not required for the Company’s LEVADEX(TM) new drug application (NDA) submission for the acute treatment of migraine…

More: continued here

Posted in Uncategorized | No Comments »

Light Hurts Even Blind Migraine Sufferers, Study Reveals How

January 11th, 2010 by admin

Researchers in the US believe they have discovered why light can make the pain of migraine worse, even in some blind people: they found photoreceptors in a part of the brain called the thalamus appear to process both light and pain, revealing for the first time that it is possible for neural pathways for pain and non-image-forming light sensitivity to converge…

More: continued here

Posted in Uncategorized | No Comments »

Abuse In Childhood Linked To Migraine And Other Pain Disorders

January 7th, 2010 by admin

Researchers from the American Headache Society’s Women’s Issues Section Research Consortium found that incidence of childhood maltreatment, especially emotional abuse and neglect, are prevalent in migraine patients…

More: continued here

Posted in Uncategorized | No Comments »

Fewer Headaches On The Horizon Thanks To Latest Guidelines

January 7th, 2010 by admin

If you’re one of the millions of headache sufferers around the world, more effective relief might be on the way in years to come. That’s because the International Headache Society has just published new research guidelines intended to stimulate more research into headache treatment, and to provide researchers with guidelines to cut health risks associated with treatment…

More: continued here

Posted in Uncategorized | No Comments »

Innovative Medical Equipment Launches Sootheaway Device For Migraine Relief

January 7th, 2010 by admin

Innovative Medical Equipment, LLC. (IME) has announced the full U.S. market release of SOOTHEAWAY - a new, thermo-electrically heated and cooled therapy device that helps relieve migraine, tension or stress headache pain in the forehead, temples, occipital and ocular / sinus regions. The compact SOOTHEAWAY device administers therapy at the optimal temperature for pain relief…

More: continued here

Posted in Uncategorized | No Comments »

« Previous Entries Next Entries »